SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Börse Stuttgart
Börse Börse Stuttgart
Symbol 49BA
EUR
  • Beigene
    Börse Börse Stuttgart
    Symbol 49BA
    EUR
  • BeiGene Ltd Ordinary Shares
    Börse Börse Frankfurt
    ISIN KYG1146Y1017 WKN: A144EN
    Symbol 49B
  • BEIGENE LTD-ADR
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol 49BA
    EUR
  • BEIGENE LTD-ADR
    Börse Gettex System der Börse München
    Symbol 49BA
    EUR
  • BEIGENE LTD-ADR
    Börse Börse Düsseldorf
    Symbol 49BA
    EUR
  • BEIGENE LTD-ADR
    Börse Börse München
    Symbol 49BA
    EUR
  • BEIGENE LTD-ADR
    Börse Quotrix System der Börse Düsseldorf
    Symbol 49BA
    EUR
  • BEIGENE LTD-ADR
    Börse Börse Berlin
    Symbol 49BA
    EUR
  • BEIGENE LTD-ADR
    Börse Börse Frankfurt
    Symbol 49BA
    EUR
  • Beigene
    Börse Nasdaq
    ISIN US07725L1026 WKN: A1437N
    Symbol BGNE
    USD
  • BeiGene, Ltd.
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US07725L1026
    MXN
  • ISIN US07725L1026 WKN: A1437N
    Symbol BGNE
    USD
  • Beigene
    Börse Hong Kong Stock Exchange
    HKD
  • HKD
  • BeiGene, Ltd.
    Börse BVMF
Symbol 49BA
Währung EUR
Börse Börse Stuttgart Zeitzone: Europe/Berlin
Firmenname BeiGene, Ltd
Marktkapitalisierung 29.239.478.400 (+- 7%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

31.242.956.800 oder 27.236.000.000

Mitarbeiter 6.067 (+- 55%)

Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:

4.600 oder 4.200 oder 9.400 Mitarbeiter

EBITDA -678.579.008
Buchwert 47.122

Beigene outperformed den DAX um +348 % vom 28.08.2017 bis 19.07.2021

36 News & Informationen zur Beigene Aktie

  • Amgen : Announces 2021 Third Quarter Dividend
    marketscreener.com

    Amgen : Announces 2021 Third Quarter Dividend

    THOUSAND OAKS, Calif., July 30, 2021 /PRNewswire/ — Amgen today announced that its Board of Directors declared a $1.76 per share dividend for the third quarter of 2021. The dividend will… | July 30, 2021

  • BeiGene Announces Approval In Canada Of BRUKINSA® (Zanubrutinib) For The Treatment Of Patients With Mantle Cell Lymphoma
    thestreet.com

    BeiGene Announces Approval In Canada Of BRUKINSA® (Zanubrutinib) For The Treatment Of Patients With Mantle Cell Lymphoma

    BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve

  • Leap Therapeutics To Present At The ESMO 2021 Virtual Congress
    thestreet.com

    Leap Therapeutics To Present At The ESMO 2021 Virtual Congress

    CAMBRIDGE, Mass., July 26, 2021 /PRNewswire/ — Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and

  • BioNTech : Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued...
    marketscreener.com

    BioNTech : Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S (Form 6-K)

    Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.

    … | July 23, 2021

  • BeiGene, Ltd. (BGNE) Fell Out Of Favor With Hedge Funds
    insidermonkey.com

    BeiGene, Ltd. (BGNE) Fell Out Of Favor With Hedge Funds

    After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms…

  • Global Bispecific Antibody Market Report 2021-2024 With Focus On China
    thestreet.com

    Global Bispecific Antibody Market Report 2021-2024 With Focus On China

    DUBLIN, July 13, 2021 /PRNewswire/ — The “Global and China Bispecific Antibody Market Insight Report, 2021-2024” report has been added to

  • Hedge Funds Are Souring On PACCAR Inc (PCAR)
    insidermonkey.com

    Hedge Funds Are Souring On PACCAR Inc (PCAR)

    In this article we will check out the progression of hedge fund sentiment towards PACCAR Inc (NASDAQ:PCAR) and determine whether it is a good investment…

  • BeiGene : Announces the Approval in China of KYPROLIS® (Carfilzomib) for Injection for Adult Patients with Relapsed or Refractory Multiple...
    marketscreener.com

    BeiGene : Announces the Approval in China of KYPROLIS® (Carfilzomib) for Injection for Adult Patients with Relapsed or Refractory Multiple Myeloma

    BeiGene, Ltd. , a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that the China National Medical Products Administration has… | July 9, 2021

  • Tezepelumab Granted Priority Review By U.S. FDA
    prnewswire.com

    Tezepelumab Granted Priority Review By U.S. FDA

    /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) and…

  • BeiGene Announces Acceptance Of A Supplemental Biologics License Application In China For Tislelizumab In Esophageal Squamous Cell...
    thestreet.com

    BeiGene Announces Acceptance Of A Supplemental Biologics License Application In China For Tislelizumab In Esophageal Squamous Cell Carcinoma (ESCC)

    BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today

  • Beigene Receives Approval for $3 Billion Shanghai STAR Listing By Investing.com
    investing.com

    Beigene Receives Approval for $3 Billion Shanghai STAR Listing By Investing.com

    Beigene Receives Approval for $3 Billion Shanghai STAR Listing

  • BeiGene : Financial Information (Form 8-K)
    marketscreener.com

    BeiGene : Financial Information (Form 8-K)

    Financial Information

    BeiGene, Ltd. previously submitted a listing application for a proposed public offering of the Company's ordinary shares and initial… | June 30, 2021

  • Ultragenyx Pharmaceutical : Management Change/Compensation (Form 8-K)
    marketscreener.com

    Ultragenyx Pharmaceutical : Management Change/Compensation (Form 8-K)

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    On June 29, 2021, the Board of… | June 30, 2021

  • Ultragenyx Appoints Corsee Sanders, Ph.D., to Board of Directors
    globenewswire.com

    Ultragenyx Appoints Corsee Sanders, Ph.D., to Board of Directors

    NOVATO, Calif., June 30, 2021 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development…

  • Primecap Odyssey Funds' 2021 Semiannual Letter to Shareholders
    gurufocus.com

    Primecap Odyssey Funds' 2021 Semiannual Letter to Shareholders

    GuruFocus Article or News written by Sydnee Gatewood and the topic is about: Discussion of markets and holdings

  • Hedge Funds Have Never Been This Bullish On Brown-Forman Corporation (BF)
    insidermonkey.com

    Hedge Funds Have Never Been This Bullish On Brown-Forman Corporation (BF)

    Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900…

  • EV Maker Xpeng Said to Get Nod for $2 Billion Hong Kong Listing
    bloombergquint.com

    EV Maker Xpeng Said to Get Nod for $2 Billion Hong Kong Listing

    (Bloomberg) — New York-traded electric-vehicle maker Xpeng Inc. has received the green light from the Hong Kong stock exchange to list in the city, according to people with knowledge of the matter, the latest homecoming share sale by a Chinese company.

  • Hedge Funds Are Selling D.R. Horton, Inc. (DHI)
    insidermonkey.com

    Hedge Funds Are Selling D.R. Horton, Inc. (DHI)

    In this article we will analyze whether D.R. Horton, Inc. (NYSE:DHI) is a good investment right now by following the lead of some of the best investors…

  • A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street
    benzinga.com

    A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street

    Pre-open movers
    U.S. stock futures traded higher in early pre-market trade after the Dow Jones tumbled more than 500 points in the previous session.
    The …

  • 5 Stocks To Watch For June 21, 2021
    benzinga.com

    5 Stocks To Watch For June 21, 2021

    Some of the stocks that may grab investor focus today are: Amazon.com, Inc. (NASDAQ: AMZN) will remain in focus with the company’s two-day Prime …

  • BeiGene : Presents Clinical Data on Sitravatinib in Combination with Tislelizumab at the AACR Annual Meeting 2021
    marketscreener.com

    BeiGene : Presents Clinical Data on Sitravatinib in Combination with Tislelizumab at the AACR Annual Meeting 2021

    The combination showed preliminary antitumor activity in patients with unresectable or metastatic melanoma refractory or resistant to PD-1/L1 inhibitors and platinum-resistant ovarian cancer in an… | April 11, 2021

  • BeiGene Presents Clinical Data On Sitravatinib In Combination With Tislelizumab At The AACR Annual Meeting 2021
    thestreet.com

    BeiGene Presents Clinical Data On Sitravatinib In Combination With Tislelizumab At The AACR Annual Meeting 2021

    BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide,

  • The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
    benzinga.com

    The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges

    Here's a roundup of top developments in the biotech space over the last 24 hours.
    Scaling The Peaks
    (Biotech Stocks Hitting 52-week Highs Jan. 14) 10X …

  • BeiGene (BGNE) Up on Label Expansion of Tislelizumab in China
    zacks.com

    BeiGene (BGNE) Up on Label Expansion of Tislelizumab in China

    BeiGene (BGNE) gains following the approval of tislelizumab for the lucrative indication of advanced squamous non-small cell lung cancer in China.

  • Stocks That Hit 52-Week Highs On Thursday
    benzinga.com

    Stocks That Hit 52-Week Highs On Thursday

    Before 10 a.m. ET Thursday, 503 stocks hit new 52-week highs.
    Noteworthy Points: Taiwan Semiconductor (NYSE:TSM) was the largest firm on a …

  • Beigene Stock Breaks Out To Record High On Cancer Drug OK In China
    investors.com

    Beigene Stock Breaks Out To Record High On Cancer Drug OK In China

    Beigene stock broke out and surged to a record high Thursday after China's regulators approved its lung cancer treatment.

  • Beigene Surges Closer To Breakout On $2.2 Billion Deal With Novartis
    investors.com

    Beigene Surges Closer To Breakout On $2.2 Billion Deal With Novartis

    Beigene stock rose Tuesday on a cancer deal with Novartis worth up to $2.2 billion, as Vir Biotechnology announced a hepatitis B deal with Gilead Sciences.

  • Why BeiGene, T2 Biosystems And Amneal Are Are Moving Today
    markets.businessinsider.com

    Why BeiGene, T2 Biosystems And Amneal Are Are Moving Today

    BeiGene (NASDAQ:BGNE) shares are trading higher after on Tuesday after the company announced a collaboration agreement with Novartis to developed …

  • Why BeiGene, T2 Biosystems And Amneal Are Are Moving Today
    benzinga.com

    Why BeiGene, T2 Biosystems And Amneal Are Are Moving Today

    BeiGene (NASDAQ: BGNE) shares are trading higher after on Tuesday after the company announced a collaboration agreement with Novartis to developed and …

  • US Divestiture Of Executive Order Banned Stocks To Benefit Mainland Investors, Asset Managers
    forbes.com

    US Divestiture Of Executive Order Banned Stocks To Benefit Mainland Investors, Asset Managers

    The Hang Seng Index gained +1.32% while the Chinese companies listed in Hong Kong and within the MSCI China All Shares Index gained +0.77% as value stocks outperformed growth stocks.

  • Twitter, Tesla, Realty Income, Cantel Medical: What to Watch When the Stock Market Opens Today
    online.wsj.com

    Twitter, Tesla, Realty Income, Cantel Medical: What to Watch When the Stock Market Opens Today

    S&P 500 futures are edging higher, pointing to muted gains after dropping on Monday.

  • BGNE Teams Up With NVS, Editas Slumps Over 15%, LLY's Drug Shines In TRAILBLAZER-ALZ, MESO On Watch
    rttnews.com

    BGNE Teams Up With NVS, Editas Slumps Over 15%, LLY's Drug Shines In TRAILBLAZER-ALZ, MESO On Watch

    Today's Daily Dose brings you news about Lilly's Alzheimer's disease trial data, BeiGene's collaboration agreement with Novartis, Mesoblast's encouraging results from phase III trial of Rexlemestrocel-L in patients with chronic heart failure, and the resignation of Editas' Chief Scientific Officer.

  • BeiGene Collaborates With Novartis To Develop Cancer Drug; To Receive Up To $1.55 Bln Payments
    markets.businessinsider.com

    BeiGene Collaborates With Novartis To Develop Cancer Drug; To Receive Up To $1.55 Bln Payments

    (RTTNews) – China-based biotechnology companyBeiGene Ltd. (BGNE) said that it will collaborate with Novartis to develop, manufacture and commercia…

  • BeiGene to Collaborate With Novartis on Tislelizumab, Will Get $650 Million Upfront Payment
    marketscreener.com

    BeiGene to Collaborate With Novartis on Tislelizumab, Will Get $650 Million Upfront Payment

    By Josh Beckerman

    BeiGene Ltd. will collaborate with Novartis AG on development of BeiGene's anti-PD-1 antibody tislelizumab and will receive a $650 million upfront cash payment.

    … | January 11, 2021

  • Amgen : To Achieve Carbon Neutrality By 2027
    marketscreener.com

    Amgen : To Achieve Carbon Neutrality By 2027

    THOUSAND OAKS, Calif., Jan. 11, 2021 /PRNewswire/ — Amgen? today announced the launch of a new seven-year environmental sustainability plan, which includes a commitment to achieve carbon… | January 11, 2021

  • Amgen To Achieve Carbon Neutrality By 2027
    prnewswire.com

    Amgen To Achieve Carbon Neutrality By 2027

    /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced the launch of a new seven-year environmental sustainability plan, which includes a commitment to achieve…

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Beigene Aktie

Das Unternehmen BeiGene, Ltd aus Kaiman Inseln beschäftigt 6.067 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Biotechnologie tätig.

Die Beigene Aktie konnte seit dem 28.08.2017 eine Rendite von bemerkenswerten 376% erwirtschaften.

Das Unternehmen BeiGene, Ltd ist in ungefähr 16 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter VanEck Vectors Biotech ETF gewichtet Beigene mit 4,11% im ETF.

Entdecke die 6 ETFs in denen BeiGene, Ltd am höchsten gewichtet ist Insgesamt in 16 ETFs enthalten

Dir gefallen die Informationen zu Beigene?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Beigene?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Beigene?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Beigene?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect